This story incorporates reporting fromBoston.com, Philadelphia Inquirer, The Boston Globe, pharmaphorum, Hartford Courant, ...

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion ...

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

Connecticut and 14 other states on Thursday agreed to a new settlement deal with the Sackler family and Purdue Pharma that ...

The settlement is the largest deal to date with the people primarily who played an “instrumental role” in driving the opioid ...

Family and company to make payment to group of US states and other parties to settle long-running litigation over OxyContin’s ...

A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half ...

The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement with Texas and 14 other states to ...

The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...